Document Detail


Interaction of ethanol, prostacyclin, and aspirin in determining human platelet reactivity in vitro.
MedLine Citation:
PMID:  2840054     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ethanol partitions into cellular membranes and alters membrane-associated phenomena in numerous cell types. Since platelet aggregation and its inhibition by prostacyclin are mediated by membrane-associated receptors and enzymes, we examined the interaction of ethanol, prostacyclin, and aspirin on human platelet reactivity. Using platelet-rich plasma, we examined the effect of increasing concentrations of ethanol (0.05% to 1.0%) on the platelet-inhibitory effects of a submaximal dose (5 x 10(-10) M) of prostacyclin, the concomitant production of cyclic 3',5'-adenosine monophosphate (AMP), and the release of thromboxane A2. Ethanol alone had little effect on platelet aggregation induced by 5 micrograms/ml collagen; however, it potentiated the inhibitory effect of prostacyclin on platelet aggregation in a dose-dependent manner in the range of 0.05% to 1.0% ethanol. Whereas prostacyclin increased platelet cyclic AMP levels, ethanol had no further effect on cyclic AMP levels. Ethanol alone reduced thromboxane A2 generation, but this effect could not totally account for the observed interaction of ethanol and prostacyclin on aggregation, since aspirin did not totally abolish the interaction. The dose range in which the ethanol/prostacyclin/aspirin interactions occur encompasses the plasma levels of ethanol that may be achieved by the consumption of alcoholic beverages. The results may, in part, explain the dose-related physiological and pathological consequences of chronic alcohol consumption on the cardiovascular system.
Authors:
J A Jakubowski; R Vaillancourt; D Deykin
Related Documents :
22170804 - Neutrophil extracellular traps contain mitochondrial as well as nuclear dna and exhibit...
6393964 - Prostacyclin biosynthesis and hypotension in relation to complement activation in rabbi...
1333254 - Ace-inhibition, kinins, and vascular pgi2 synthesis.
214824 - Prostacyclin: a potent stimulator of adrenal steroidogenesis.
9114964 - An inherited platelet function defect in a simmental crossbred herd.
2209604 - An anti-inflammatory protein secreted from the rat seminal vesicle epithelium inhibits ...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Arteriosclerosis (Dallas, Tex.)     Volume:  8     ISSN:  0276-5047     ISO Abbreviation:  Arteriosclerosis     Publication Date:    1988 Jul-Aug
Date Detail:
Created Date:  1988-08-18     Completed Date:  1988-08-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8401388     Medline TA:  Arteriosclerosis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  436-41     Citation Subset:  IM    
Affiliation:
Department of Hemostasis Research, Boston Veterans Administration Medical Center, Massachusetts 02130.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aspirin / pharmacology*
Blood Platelets / drug effects,  metabolism
Collagen / pharmacology
Cyclic AMP / biosynthesis
Dose-Response Relationship, Drug
Drug Interactions
Epoprostenol / pharmacology*
Ethanol / pharmacology*
Humans
Platelet Aggregation / drug effects*
Thromboxane A2 / metabolism
Chemical
Reg. No./Substance:
35121-78-9/Epoprostenol; 50-78-2/Aspirin; 57576-52-0/Thromboxane A2; 60-92-4/Cyclic AMP; 64-17-5/Ethanol; 9007-34-5/Collagen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinicopathologic analysis of carcinoma of the breast in an African population.
Next Document:  Lack of cross sensitivity between captopril and enalapril.